Thromboelastometry Prediction Utility for Risk of Abortion

Completed

Conditions studied: Pregnancy Trimester, First, Abortion, Threatened

In brief

This study will use thromboelastometry in ED patients with vaginal bleeding, as well as healthy pregnant controls, to determine if abnormal results are associated with the presence of vaginal bleeding as well as later complications during pregnancy.

Key facts

Study ID

NCT03548701

Run by

Icahn School of Medicine at Mount Sinai

People needed

98

Starts

2018-06-04

Expected to finish

2019-05-15

Last updated by the study team

2020-06-01

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subjects will include pregnant women seen in the ED and OB clinic.
• The ED patients will include those seen for vaginal bleeding during pregnancy at less than 20 weeks gestation.
• OB Clinic patients will include those seen for first prenatal visit at which blood draw is performed, as long as this is also within 20 weeks estimated gestational age.

You may not qualify if…

• Patients with known histories of recurrent miscarriage, previously diagnosed thrombophilia, or other coagulopathy will be excluded.
• Patients with ectopic pregnancies will also be excluded.

Where it is running

• Mount Sinai Hospital — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.